Data availability
All raw data is available from the 1st author and corresponding authors.
Notes
Explained in supplementary section.
Explained in supplementary section.
Explained in supplementary section.
References
Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol. 2008;40:257–67.
Ozment CP, Mamo LB, Campbell ML, Lokhnygina Y, Ghio AJ, Turi JL. Transfusion-related biologic effects and free hemoglobin, heme, and iron. Transfusion. 2013;53:732–40.
Sohn N, Marcoux J, Mycyk T, Krahn J, Meng Q. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Perfusion. 2009;24:231–7.
Satoh T, Xu Q, Wang L, Gladwin MT. Hemolysis-mediated Toxicity during cardiopulmonary bypass ameliorated by Inhaled Nitric Oxide gas. Am J Respir Crit Care Med. 2018;198:1244–6.
Bolten SN, Rinas U, Scheper T. Heparin: role in protein purification and substitution with animal-component free material. Appl Microbiol Biotechnol. 2018;102:8647–60.
Funding
None.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethics approval
Obtained vide reference NK/7490/Study/491 dated 02/07/2021.
Informed consent statement
Informed consent was taken from volunteers taking part in the study.
Conflict of interest
Authors have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 410 kb)
Rights and permissions
About this article
Cite this article
Surender, Chowdhary, S., Kumar, D. et al. Whether heparin causes hemolysis: an in silico and in vitro study. Indian J Thorac Cardiovasc Surg 38, 566–569 (2022). https://doi.org/10.1007/s12055-022-01340-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-022-01340-3